blog

Digitized Predictive Analysis To Drive Facial Rejuvenation Market At A CAGR Of 5.0%

 The pharmaceutical industry is making use of AI for discovering new-fangled drugs. January 2020 witnessed the invention of the very first drug molecule using AI, whose patent lay with Japanese and British scientists. The medicine is being used for treating OCD (obsessive-compulsive disorder). Likewise, several promising formulas are being discovered as an outcome of AI-enabled lab experimenting. This would how the facial rejuvenation market look in the near future.

Increasing consumer spending on aesthetic treatments coupled with growing popularity of non-surgical procedures are key factors driving the global facial rejuvenation market. Macro factors including rising employability and promising economic growth in Asia Pacific to promote nice-to-have services are projected to contribute to the adoption of facial rejuvenation treatments and present potential growth opportunities to providers and other stakeholders in the facial rejuvenation market.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3639  

As per a report by Persistence Market Research (PMR), the global facial rejuvenation market, expanding at a steady 5.0% CAGR, is likely to reach a valuation of US$ 39.4 Bn by 2028. However, adverse reactions associated with facial aesthetics products, high procedure costs, and lack of trained professionals are some key factors projected to restrain the adoption of facial rejuvenation procedures.

Company Profiles:

  • Merz Pharma
  • Anika Therapeutics, Inc.
  • Lumenis
  • Galderma (Nestlé Skin Health)
  • Contura
  • Daewoong Pharmaceutical Co., Ltd.
  • llergan plc (Actavis plc)
  • Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3639

global-facial-rejuvenation-market.jpg

Rising Adoption of Minimally Invasive Procedures and Combination Therapies Driving the Adoption of Facial Rejuvenation Treatments

Considering the advancements in cosmetic treatments, a number of consumers are preferring least invasive, less painful procedures. From minimally invasive injectables to non-invasive topical skin treatments, facial rejuvenation treatments have hugely evolved from equipment-based procedures, further complementing the growing adoption of facial rejuvenation treatments among patients with specific cosmetic concerns, the most common being anti-aging.

PMR’s study on the global facial rejuvenation market reveals that the availability of products with much faster results are driving the growth of facial rejuvenation market, for instance, derma fillers. Moreover, long lasting effect of treatments with clinically-approved products, results in much higher adaptability and retains the trust of patients.

In terms of products, Botulinum toxin injection is the most preferred owing to its dynamic used in aesthetic clinical practice. Moreover, positive response from regulatory authorities for different set of facial problems, is also complementing the adoption of botulinum.

Combination therapies including botulinum and derma fillers is also gaining traction considering its higher efficiency, further driving the adoption of facial rejuvenation treatment. Botox injection decreases muscle movement and dermal fillers such as hyaluronic acid products are used for creating more youthful looking appearance.

In developed economies including U.S, U.K, Japan, and South Korea, combination therapies of...

Do you already have an account? Log in here

Join the discussion

0 comments

To read and post comments you need to login or register